Investors & Partners at Versant Ventures

Brad Bolzon

Chairman, Managing Director, Versant Ventures

Brad Bolzon is Chairman and Managing Director at Versant Ventures, a leading venture capital firm focused on advancing innovation in biotech and digital health. In his role, Bolzon leverages deep expertise in life sciences investing to identify and support transformative companies at the intersection of biology and technology. His strategic leadership at Versant positions him to guide portfolio companies through critical growth stages while building meaningful connections across the healthcare and biotech ecosystems. With a focus on both therapeutic innovation and digital health solutions, Bolzon is instrumental in shaping Versant's investment thesis and driving value creation for founders and stakeholders. His work spans early-stage venture investing through growth capital, with particular attention to technologies that address significant unmet clinical needs and improve healthcare outcomes.

Carlo Rizzuto

Managing Director, Versant Ventures

Carlo Rizzuto is a Managing Director at Versant Ventures, a prominent venture capital firm focused on investments in biotech and digital health. In his role, Rizzuto leverages his expertise to identify and support innovative companies transforming the life sciences and healthcare technology sectors. At Versant Ventures, he works with entrepreneurs developing breakthrough therapeutics, diagnostics, and digital health solutions that address significant unmet medical needs. His investment focus spans early to late-stage biotech companies and digital health platforms poised to make meaningful impact on patient outcomes and healthcare delivery. Rizzuto's career in venture capital reflects a deep commitment to advancing innovation at the intersection of biology and technology, where he helps navigate complex regulatory landscapes and scaling challenges inherent to healthcare ventures.

Clare Ozawa

Managing Director, Versant Ventures

Clare Ozawa is a Managing Director at Versant Ventures, a leading venture capital firm focused on transforming healthcare through innovative investments. With a strategic focus on biotech and digital health sectors, Ozawa identifies and supports breakthrough companies poised to address critical unmet medical needs. As a Managing Director, she plays a key role in sourcing, evaluating, and nurturing portfolio companies, leveraging deep industry expertise to guide investments from early-stage through scaling phases. Ozawa's work at Versant Ventures positions her at the forefront of healthcare innovation, where she partners with talented entrepreneurs and scientific teams to drive the next generation of therapeutic and digital health solutions. Her professional focus on biotech and digital health reflects a commitment to advancing technologies that improve patient outcomes and reshape the healthcare landscape.

Robin Praeger

Managing Director/Advisor, Versant Ventures

Robin Praeger is a Managing Director and Advisor at Versant Ventures, a leading venture capital firm specializing in biotech and digital health investments. With a focus on early-stage and growth-stage companies in the life sciences sector, Praeger brings extensive expertise in identifying and supporting innovative healthcare technologies and therapeutics. At Versant Ventures, Praeger evaluates investment opportunities across the biotech and digital health landscapes, leveraging deep industry knowledge to help portfolio companies achieve significant milestones. His professional background and strategic perspective have made him a valuable advisor to emerging companies seeking to transform healthcare through scientific innovation and digital solutions. Praeger remains actively engaged in the venture capital ecosystem, contributing to the firm's mission of backing transformative healthcare innovations.

Tom Woiwode

Managing Director, Versant Ventures

Tom Woiwode is a Managing Director at Versant Ventures, a leading venture capital firm focused on innovative solutions in biotech and digital health. In his role, he identifies and invests in transformative healthcare companies addressing significant unmet medical needs. With deep expertise spanning biotechnology and digital health technologies, Tom brings strategic insight to portfolio companies navigating complex regulatory landscapes and commercialization challenges. His investment thesis centers on backing visionary entrepreneurs developing breakthrough therapeutics, diagnostics, and digital health platforms that have the potential to meaningfully improve patient outcomes. Through his work at Versant Ventures, Tom actively supports early and growth-stage companies in scaling their operations, refining their go-to-market strategies, and achieving key clinical and commercial milestones.